BDRX
HEALTHCAREBiodexa Pharmaceuticals Plc
$4.42-0.06 (-1.34%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BDRX Today?
No stock-specific AI insight has been generated for BDRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.86$96.50
$4.42
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-3.39
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin—
Debt / Equity—
Trading
Volume310K
Avg Volume (10D)—
Shares Outstanding648K
BDRX News
20 articles- European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday TradingYahoo Finance·May 7, 2026
- European Equities Traded in the US as American Depositary Receipts Higher in Tuesday TradingYahoo Finance·May 5, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week LowerYahoo Finance·May 4, 2026
- European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for WeekYahoo Finance·May 1, 2026
- European Equities Traded in US as ADRs Ease in Thursday TradingYahoo Finance·Apr 23, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday TradingYahoo Finance·Apr 22, 2026
- European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday TradingYahoo Finance·Apr 21, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 10, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday TradingYahoo Finance·Apr 7, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Monday TradingYahoo Finance·Apr 6, 2026
- Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial SuppliesYahoo Finance·Apr 2, 2026
- BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction AreasYahoo Finance·Mar 30, 2026
- Preliminary Results for the Year Ended 31 December 2025Yahoo Finance·Mar 27, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday TradingYahoo Finance·Mar 27, 2026
- European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday TradingYahoo Finance·Mar 25, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Tuesday TradingYahoo Finance·Mar 24, 2026
- European Equities Traded in the US as American Depositary Receipts Climb in Monday TradingYahoo Finance·Mar 23, 2026
All 20 articles loaded
Price Data
Open$3.10
Previous Close$4.48
Day High$3.12
Day Low$3.01
52 Week High$96.50
52 Week Low$2.86
52-Week Range
$2.86$96.50
$4.42
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-3.39
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin—
Debt / Equity—
Trading
Volume310K
Avg Volume (10D)—
Shares Outstanding648K
About Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in the United Kingdom, rest of Europe, and internationally. The company is headquartered in Cardiff, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—